Skip to main content

Zentalis Pharmaceuticals, Inc.

ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001725160

In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.

13F holders, Q2 2025

Institutional positions in Zentalis Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
117
−15 vs. Q1 2025
Shares held
55.6M
−2.85M (−4.9%) vs. Q1 2025
Total value
$64.5M
−$28.4M (−30.6%) vs. Q1 2025
New holders
22
34 more added
Sold out
37
44 more reduced

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 117 institutions
Q1 2021: 95 institutionsQ2 2021: 120 institutionsQ3 2021: 116 institutionsQ4 2021: 139 institutionsQ1 2022: 128 institutionsQ2 2022: 122 institutionsQ3 2022: 121 institutionsQ4 2022: 106 institutionsQ1 2023: 110 institutionsQ2 2023: 134 institutionsQ3 2023: 137 institutionsQ4 2023: 120 institutionsQ1 2024: 142 institutionsQ2 2024: 145 institutionsQ3 2024: 136 institutionsQ4 2024: 142 institutionsQ1 2025: 132 institutionsQ2 2025: 117 institutionsQ3 2025: 99 institutionsQ4 2025: 86 institutionsQ1 2026: 102 institutionsQ2 2026: 114 institutions
Value heldQ2 2025: $64.5M
Q1 2021: $1.58BQ2 2021: $2.13BQ3 2021: $2.75BQ4 2021: $3.61BQ1 2022: $2.05BQ2 2022: $1.64BQ3 2022: $1.27BQ4 2022: $1.30BQ1 2023: $1.15BQ2 2023: $2.32BQ3 2023: $1.61BQ4 2023: $1.23BQ1 2024: $1.34BQ2 2024: $314.3MQ3 2024: $261.2MQ4 2024: $195.2MQ1 2025: $92.9MQ2 2025: $64.5MQ3 2025: $79.7MQ4 2025: $54.9MQ1 2026: $101.7MQ2 2026: $228.9M
Institutions holding ZNTL and their total value by quarter
QuarterHoldersValue
Q2 2026114$228.9M
Q1 2026102$101.7M
Q4 202586$54.9M
Q3 202599$79.7M
Q2 2025117$64.5M
Q1 2025132$92.9M
Q4 2024142$195.2M
Q3 2024136$261.2M
Q2 2024145$314.3M
Q1 2024142$1.34B
Q4 2023120$1.23B
Q3 2023137$1.61B
Q2 2023134$2.32B
Q1 2023110$1.15B
Q4 2022106$1.30B
Q3 2022121$1.27B
Q2 2022122$1.64B
Q1 2022128$2.05B
Q4 2021139$3.61B
Q3 2021116$2.75B
Q2 2021120$2.13B
Q1 202195$1.58B

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q1 2025.

Institutions holding ZNTL in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Primecap Management Co1,027,620$1.19M0.00%−237,000−18.7%Reduced
Two Sigma Investments, LP1,093,053$1.27M0.00%+543,719+99.0%Added
Morgan Stanley1,097,651$1.27M0.00%+3,693+0.3%Added
Gsa Capital Partners LLP1,133,375$1.31M0.09%+591,400+109.1%Added
D. E. Shaw & Co., Inc.1,197,624$1.39M0.00%+79,847+7.1%Added
Two Sigma Advisers, LP1,275,914$1.48M0.00%+433,314+51.4%Added
Decheng Capital LLC1,323,327$1.54M0.39%−696,435−34.5%Reduced
Tybourne Capital Management (HK) Ltd1,478,152$1.71M4.96%+516,666+53.7%Added
Renaissance Technologies LLC1,529,553$1.77M0.00%+703,512+85.2%Added
Tang Capital Management LLC1,550,000$1.80M0.09%+50,000+3.3%Added
Almitas Capital LLC1,599,266$1.86M0.47%−111,655−6.5%Reduced
BlackRock, Inc.1,741,747$2.02M0.00%−2,487,750−58.8%Reduced
Opaleye Management Inc.1,924,300$2.23M0.45%−60,700−3.1%Reduced
Acadian Asset Management LLC2,799,020$3.24M0.01%+124,985+4.7%Added
Vanguard Group Inc2,884,632$3.35M0.00%−375,980−11.5%Reduced
Millennium Management LLC3,476,808$4.03M0.00%+407,294+13.3%Added
Matrix Capital Management Company, LP13,959,973$16.2M7.27%00.0%Unchanged
Nuveen, LLC0$00.00%−507,527−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−159,836−100.0%Sold out
Bank of New York Mellon Corp0$00.00%−156,115−100.0%Sold out
Algert Global LLC0$00.00%−122,348−100.0%Sold out
Verition Fund Management LLC0$00.00%−122,282−100.0%Sold out
Alliancebernstein L.P.0$00.00%−109,538−100.0%Sold out
Rhumbline Advisers0$00.00%−84,542−100.0%Sold out
Exchange Traded Concepts, LLC0$00.00%−67,401−100.0%Sold out
Alps Advisors Inc0$00.00%−55,033−100.0%Sold out
Virtus Investment Advisers, Inc.0$00.00%−52,449−100.0%Sold out
American Century Companies Inc0$00.00%−46,900−100.0%Sold out
Deutsche Bank AG0$00.00%−42,804−100.0%Sold out
Intech Investment Management LLC0$00.00%−40,279−100.0%Sold out
Mirae Asset Global ETFs Holdings Ltd.0$00.00%−34,202−100.0%Sold out
Alpine Global Management, LLC0$00.00%−30,164−100.0%Sold out
Corebridge Financial, Inc.0$00.00%−27,996−100.0%Sold out
Bank of Montreal0$00.00%−23,459−100.0%Sold out
Manufacturers Life Insurance Company, The0$00.00%−22,874−100.0%Sold out
Zacks Investment Management0$00.00%−22,340−100.0%Sold out
New York State Common Retirement Fund0$00.00%−21,891−100.0%Sold out
Cerity Partners LLC0$00.00%−20,501−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−18,710−100.0%Sold out
Voya Investment Management LLC0$00.00%−17,282−100.0%Sold out
JustInvest LLC0$00.00%−16,966−100.0%Sold out
State Board of Administration of Florida Retirement System0$00.00%−16,619−100.0%Sold out
CIBC World Markets Corp0$00.00%−12,680−100.0%Sold out
ProShare Advisors LLC0$00.00%−12,370−100.0%Sold out
Police & Firemen's Retirement System of New Jersey0$00.00%−11,596−100.0%Sold out
Ameritas Investment Partners, Inc.0$00.00%−5,837−100.0%Sold out
Legal & General Group Plc0$00.00%−4,940−100.0%Sold out
California State Teachers Retirement System0$00.00%−4,141−100.0%Sold out
Amalgamated Bank0$00.00%−1,987−100.0%Sold out
Point72 (DIFC) Ltd0$00.00%−1,474−100.0%Sold out
Sterling Capital Management LLC0$00.00%−1,027−100.0%Sold out
UMA Financial Services, Inc.0$00.00%−524−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−167−100.0%Sold out
Rothschild Investment LLC0$00.00%−70−100.0%Sold out